[4-(2-氯-4-硝基苯基)-1-哌嗪基](5-甲基-3-苯基-4-异恶唑基)甲酮
甲酮结构式](https://image.chemsrc.com/caspic/401/341001-38-5.png)
[4-(2-氯-4-硝基苯基)-1-哌嗪基](5-甲基-3-苯基-4-异恶唑基)甲酮结构式
|
常用名 | [4-(2-氯-4-硝基苯基)-1-哌嗪基](5-甲基-3-苯基-4-异恶唑基)甲酮 | 英文名 | Nucleozin |
|---|---|---|---|---|
| CAS号 | 341001-38-5 | 分子量 | 426.85300 | |
| 密度 | 1.371 | 沸点 | 673.8ºC at 760 mmHg | |
| 分子式 | C21H19ClN4O4 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 361.3ºC | |
| 符号 |
GHS06 |
信号词 | Danger |
|
A GFP-tagged nucleoprotein-based aggregation assay for anti-influenza drug discovery and antibody development.
Analyst 138(20) , 6073-80, (2013) Influenza is a viral pandemic that affects millions of people worldwide. Seasonal variations due to genetic shuffling and antigenic drifts in the influenza viruses have necessitated continual updating of therapeutics. The growing resistance to current influen... |
期刊文献综述：
更多...